Loading…

Clarivate PLCCLVTCompetitor analysis, valuation and peers

United States · USD·Industrials›Miscellaneous Commercial Services

Provider of intellectual property, scientific and academic research information, analytics and software services.

Momentum strong 70
Mkt cap
$1.38B
US dollars, full cap
Free float
52%
of shares outstanding
$/day
$9.03M
20-day average traded
Fwd P/E
3.5×
forward earnings
ROIC−WACC
-5.5 pp
WACC 7.2%
Hurdle
-1 pp
Req g minus delivered
Next earnings
104 days
2 Mar 2027
Close · USD$2.16
1D-1.4%
1W-6.9%
1M+21.4%
3M+4.3%
6M-12.2%
YTD-35.3%
1Y-35.9%
ATR %7.0%
Beta0.56
52w lowhigh44.2% off high

What Clarivate does

Provider of intellectual property, scientific and academic research information, analytics and software services.

Earns most of its income from annual subscriptions to databases and software that customers use every day, so revenue is recurring and tied to renewal rates; trademark and patent filing services add transaction-based income. It was carved out of Thomson Reuters in 2016 and has grown by acquisition.

Products and services

  • IP/patent search & analytics (CompuMark, Derwent)
  • Scientific/academic research analytics (Web of Science)
  • Life sciences/regulatory intelligence software

Customers

  • Law firms/corporate IP departments
  • Academic institutions/researchers
  • Pharmaceutical companies

Where it sits in the supply chain

  • Business services/information
  • IP & scientific information services
  • Patent/IP data, academic research…

What could go right

  • IP filing volume growth (especially China/emerging markets)
  • Academic research analytics demand

What could go wrong

  • High leverage/debt load post-acquisitions
  • Integration risk from multiple large M&A deals

Moat: narrow (data, switching costs, brand). Proprietary, decades-deep IP and citation databases are difficult and costly for rivals to replicate.

Headquarters: London, United Kingdom · Founded: 2016 · Employees: 12,000

Named competitors

Clarivate at a glance

Size Clarivate (CLVT) is a United States Industrials company (Miscellaneous Commercial Services) with a market value of $1.38B, the 2026th largest of 3,085 United States companies the cockpit tracks. Shares closed at $2.16 on 18 Nov 2026.

Performance Over six months the shares fell 12.2%, against -17.4% for the median peer and -2.2% for the United States market (cap-weighted) — 9th highest of 21 in its peer set.

Growth Revenue fell 9.2% over the last twelve months (peer median +8.9%); the operating margin is 7.9% (peer median 7.1%).

Valuation It trades at 3.5× forward earnings against a peer median of 21.2× (cheapest of 17).

Price implies For today's price to make sense, revenue must grow about 13% a year for seven years (Req g). Recent delivered growth is +14%, so the hurdle is -1 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 5.5 points below its cost of capital (7.2% WACC).

Short interest Short interest is 7.6% of the free float (30 Oct 2026).

Next results Next results expected around 2 Mar 2027 (exchange calendar; dates can move).

Relative performance

608010021 May 202621 Aug 202618 Nov 2026CLVT 89Peer median 82
Six months, rebased to 100: Clarivate against the median of its 20 peers (local-currency closes).

Clarivate financials

Reported figures in USD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue$2.27B$2.46B$2.56B$2.63B$2.66B
Revenue growth—-4%-3%-1%—
Gross profit$829M$864M$960M$1.01B$995M
EBITDA$901M$936M$960M$983M$976M
Net income-$386M-$201M-$637M-$911M-$3.96B
Free cash flow$322M$365M$337M$502M$304M
Capital expenditure$237M$263M$289M$242M$203M
Total debt$4.18B$4.48B$4.59B$4.81B$5.10B

Quarterly statements and history in the cockpit →

Clarivate competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-40%-20%0%+20%0%+20%CMPDI688202301413002607DBGICFI300725CRAI2384AFRY688128603406600654600662002338MOL9746688351301500CLVT6-month return →1-month return →
Up and to the right = strong over both horizons. Clarivate is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%0×200×400×688202301413002607DBGICFI300725CRAI2384688128600662002338MOL000681688351CLVTRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Clarivate is the large dot.

Capital: growth delivered against growth the price implies

-20%0%+20%+40%+60%-25%0%25%50%CMPDI002607DBGICFI3007252384AFRY600654MOL9746000681688351CLVTGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Clarivate is the large dot.

Clarivate competitors and peer comparison

Head to head with its named competitors (CLVT vs REL.L vs TRI.TO)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Clarivate CLVT$1.38B-12%-9%8%3.5×13.2%
Relx REL.L$67.6B+21%+2%32%20.9×1.7%
Thomson Reuters TRI.TO$45.0B+27%+6%26%23.7×2.1%

How Clarivate compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Clarivate against its 20 peers (data as of 18 Nov 2026)
MeasureCLVTPeer medianRank in peer set
1-month return+21.4%-2.3%3rd highest of 21
6-month return-12.2%-17.4%9th highest of 21
Distance from 52-week high-44.2%-35.4%8th lowest of 21
Revenue growth (TTM)-9.2%+8.9%3rd lowest of 21
Operating margin7.9%7.1%10th highest of 21
Forward P/E3.5×21.2×cheapest of 17
Growth the price implies (Req g, 7 yrs)13.2%6.6%6th most demanding of 16
Growth delivered (Del g)+14.4%+8.1%4th highest of 16
Hurdle (Req g minus delivered)-1.1 pp-4.5 pp7th most demanding of 16
ROIC minus cost of capital-5.5 pp+0.7 pp6th lowest of 20
EV / EBITDA5.9×8.4×2nd cheapest of 9
Net debt / EBITDA4.4×1.9×most indebted of 9

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Clarivate CLVTUnited States$1.38B-12%-9%8%3.5×13.2%+14.4%
Central Mine Planning & Design Institute CMPDI.NSIndia$1.38B-22%+10%33%n/a4.5%+18.7%
Shanghai Medicilon 688202.SSChina$1.39B+8%+42%-2%85.1×n/an/a
Shenzhen Ampron Technology 301413.SZChina$1.40B-28%+11%2%387.2×n/an/a
Offcn Education Technology 002607.SZChina$1.40B-40%-2%13%34.7×15.7%-27.6%
Derichebourg DBG.PAFrance$1.37B-18%-3%5%8.8×6.7%+6.3%
ICF International ICFIUnited States$1.40B+14%-5%8%10.4×-2.5%+4.4%
PharmaBlock Sciences (Nanjing) 300725.SZChina$1.36B+5%+11%11%37.5×24.2%+14.1%
CRA International CRAIUnited States$1.35B+46%+13%10%23.3×6.6%+8.1%
SBS 2384.TJapan$1.35B+26%+17%5%13.9×-4.7%+13.8%
AFRY AFRY.STSweden$1.42B+5%-4%7%12.5×-2.2%+6.3%
China National Electric Apparatus Research Institute 688128.SSChina$1.35B-17%+8%11%14.7×3.2%+13.5%
Yangzhou Tinfulong 603406.SSChina$1.42B-29%-4%12%n/a6.1%+10.6%
China Security 600654.SSChina$1.34B-31%-30%-1%n/a56.0%+0.4%
Shanghai Foreign Service 600662.SSChina$1.42B-14%+1%2%13.2×n/an/a
Changchun Up Optotech 002338.SZChina$1.34B-41%+22%2%43.1×n/an/a
Moltiply MOL.MIItaly$1.45B+12%+20%16%14.0×10.9%+21.0%
TKC 9746.TJapan$1.31B+22%+5%20%19.1×-10.1%+5.7%
Visual China 000681.SZChina$1.46B-34%-9%4%37.6×57.8%+6.5%
Shanghai MicroPort EP Medtech 688351.SSChina$1.31B-30%+20%3%137.1×42.5%+26.7%
Guangdong Feinan Resources Recycling 301500.SZChina$1.49B-38%+42%7%n/an/an/a

Questions

Who are Clarivate's main competitors?
Named competitors: RELX (REL.L), Thomson Reuters (TRI.TO). The cockpit's measured peer set (industry) also includes Central Mine Planning & Design Institute (CMPDI.NS), Shanghai Medicilon (688202.SS), Shenzhen Ampron Technology (301413.SZ), Offcn Education Technology (002607.SZ), Derichebourg (DBG.PA), ICF International (ICFI).
Is Clarivate expensive compared with its peers?
On forward p/e it trades at 3.5× against a peer median of 21.2×, cheapest of 17 in its peer set. For today's price to make sense, revenue must grow about 13% a year for seven years (Req g). Recent delivered growth is +14%, so the hurdle is -1 pp: the price already allows for a slowdown.
How has Clarivate stock performed?
Over six months to 18 Nov 2026 the shares returned -12.2% against -17.4% for the median peer; over one year -35.9%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.